Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)
Malaysia · Delayed Price · Currency is MYR 0.3050
-0.0100 (-3.17%)
At close: Aug 11, 2026
KLSE:MGRC Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 46 | 33 | 47 | 61 | 61 | 107 | |
Market Cap Growth | 72.05% | -30.44% | -22.47% | 0.84% | -43.65% | -39.15% |
Enterprise Value | 43 | 33 | 48 | 61 | 60 | 86 |
Last Close Price | 0.30 | 0.24 | 0.34 | 0.45 | 0.47 | 0.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | - | - | 14.90 |
Forward PE | - | 8.94 | 8.94 | 9.47 | 12.08 | - |
PS Ratio | 4.94 | 4.11 | 8.57 | 6.38 | 7.24 | 3.79 |
PB Ratio | 2.52 | 2.23 | 2.69 | 2.76 | 2.15 | 2.76 |
P/TBV Ratio | 2.88 | 2.67 | 3.32 | 3.38 | 2.72 | 3.35 |
P/FCF Ratio | 52.29 | 31.87 | - | - | - | - |
P/OCF Ratio | 48.05 | 29.80 | - | - | - | 1887.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 4.58 | 4.08 | 8.78 | 6.35 | 7.15 | 3.05 |
EV/EBITDA Ratio | 40.83 | - | - | - | - | 12.67 |
EV/EBIT Ratio | - | - | - | - | - | 14.35 |
EV/FCF Ratio | 48.56 | 31.70 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.06 | 0.08 | 0.09 | 0.09 | 0.05 | 0.04 |
Debt / EBITDA Ratio | 1.10 | - | - | - | - | 0.23 |
Debt / FCF Ratio | 1.31 | 1.19 | - | - | - | - |
Net Debt / Equity Ratio | -0.12 | -0.15 | -0.08 | -0.24 | -0.01 | -0.49 |
Net Debt / EBITDA Ratio | -3.24 | 1.92 | 0.42 | 0.29 | 0.04 | -2.79 |
Net Debt / FCF Ratio | -2.54 | -2.19 | 1.56 | 0.32 | 0.02 | 14.93 |
Asset Turnover | 0.44 | 0.39 | 0.23 | - | 0.23 | 0.88 |
Inventory Turnover | 3.74 | 4.37 | 2.70 | - | 7.98 | 42.05 |
Quick Ratio | 5.14 | 2.07 | 2.15 | 5.84 | 11.65 | 17.56 |
Current Ratio | 5.53 | 3.18 | 3.26 | 8.01 | 11.97 | 18.08 |
Return on Equity (ROE) | -5.08% | -17.29% | -22.77% | - | -43.89% | 25.34% |
Return on Assets (ROA) | -1.14% | -6.90% | -12.19% | - | -23.29% | 11.64% |
Return on Invested Capital (ROIC) | -2.74% | -15.84% | -28.59% | -89.58% | -56.80% | 42.70% |
Return on Capital Employed (ROCE) | -2.00% | -14.40% | -24.90% | -84.10% | -46.60% | 15.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -1.07% | -7.23% | -8.85% | -31.20% | -23.53% | 6.71% |
FCF Yield | 1.91% | 3.14% | -2.00% | -27.91% | -37.17% | -1.19% |
Buyback Yield / Dilution | -1.33% | - | 14.93% | -26.44% | -3.69% | -14.37% |
Total Shareholder Return | -1.33% | - | 14.93% | -26.44% | -3.69% | -14.37% |